---
source: https://ir.thermofisher.com/investors/news-events/news/news-details/2024/Thermo-Fisher-Scientific-Completes-Acquisition-of-Olink-Announces-Commencement-of-Subsequent-Offering-Period/default.aspx
date: 2024-07-10
type: Company
---

# Thermo Fisher Acquires Olink for $3.1B

Thermo Fisher Scientific completed acquisition of Olink Holding AB, a leading provider of next-generation proteomics solutions.

## Transaction Details

- **Announced:** October 2023
- **Completed:** July 10, 2024
- **Price:** ~$3.1B net of acquired cash ($26/share)
- **Premium:** 74% to closing price on October 16, 2023
- **Ownership:** 98.2% of outstanding shares

## About Olink

- **Headquarters:** Uppsala, Sweden
- **Offices:** Boston, Shanghai, Singapore, Tokyo
- **Technology:** Proximity Extension Assay (PEA)
- **Library:** 5,300+ validated protein biomarker targets
- **Publications:** 1,400+ scientific publications
- **Revenue:** On track for $200M+ in 2024

## Strategic Rationale

- Becomes part of Life Sciences Solutions segment
- PEA offers high-throughput protein analysis
- Quantitative PCR and next-generation sequencing readout
- Expected mid-teens organic growth

## Market Position

- Olink holds **40-50% market share** in high-plex proteomics
- Spun out of Uppsala University lab of Prof. Ulf Landegren

## Regulatory

- UK CMA: Phase 1 unconditional clearance
- German Federal Cartel Office: Phase 2 unconditional clearance (June 2024)
